Invention in the REGENERATIVE MEDICINE is what we do every day, benefits of patients is our final goal

Our Products

Home > Products

Cata #: Name of Product: Price:
rAB-1762 Recombinant anti-Human CD19 sFV Antibody $150

Recombinant anti-Human CD19 sFV Antibody

Product Name: Recombinant anti-Human CD19 sFV Antibody
Catalog #:  rAB-1762
Manufacture:  LD Biopharma, Inc.

Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. Human CD19 gene encodes a cell surface molecule, which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. Anti-CD19 antibody has been used for purifying B cell or targeting B cell derived lymphoma, such as anti-CD19 single chain antibody mediated chimeric antigen receptor modified T cell (CAR-T) technology.

Anti-human CD19 specific Single Chain Variable Fragment Antibody: sFV (Human L-link-H single chain format) gene was constructed using codon optimization gene synthesis technology with 29 aa N-terminal T7 / His / TEV cleavage site Tag and expressed in E.coli as inclusion bodies. The final product was refolded using our unique “temperature shift inclusion body refolding” technology and chromatographically purified.

Gene Symbol:  Anti-human CD19 sFV 
Accession Number:  ADM64594
Species:  Human
Package Size:  40 µg / Vial   
Composition: 0.4 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose and DTT.
Storage: In Liquid. Keep at -80°C for long term storage. Product is stable at 4 °C for at least 30 days.
Key Reference: Kochenderfer,J.N., et al., Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor J. Immunother. 32 (7), 689-702 (2009)
Kochenderfer,J.N., et al., Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116 (20), 4099-4102 (2010)

1. As reagent for detection of human CD19 in ELISA or western blot assay.

2. As antigen for generating anti-human CD19 sFV antibody.

Quality Control: Purity: > 90% by SDS-PAGE.
Download Datasheet